Prevalence and outcomes of intermediate saphenous vein graft lesions: Findings from the stenting of saphenous vein grafts randomized-controlled trial

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2468-2473

  Abdel Karim, Abdul Rahman R ^a,b   Da Silva, Monica ^a,b   Lichtenwalter, Christopher ^c   De Lemos, James A ^a,b   Obel, Owen ^a,b   Addo, Tayo ^a,b   Roesle, Michele ^a   Haagen, Donald ^a   Rangan, Bavana V ^a   Makke, Lorenza ^a   Jeroudi, Omar M ^a,b   Raghunathan, Deepa ^a,b   Saeed, Bilal ^d   Bissett, Joseph K ^e   Sachdeva, Rajesh ^e   Voudris, Vassilios V ^f   Karyofillis, Panagiotis ^f   Kar, Biswajit ^g   Rossen, James ^h   Fasseas, Panayotis ⁱ   Berger, Peter ^d   Banerjee, Subhash ^a,b   Brilakis, Emmanouil S ^a,b   more..

^a Veterans Affairs North Texas Health Care System   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Cardiovascular and Arrhythmia Institute   (United States)

^d GEISINGER MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f ONASSIS CARDIAC SURGERY CENTER   (Greece)

^g MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Percutaneous Coronary Interventions; Saphenous vein grafts; Stents

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME; VEIN GRAFT DISEASE; VEIN OCCLUSION; CLINICAL TRIAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SAPHENOUS VEIN; STENT; TRANSPLANTATION;

ACUTE CORONARY SYNDROME; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; SAPHENOUS VEIN; STENTS;

EID: 84885653004     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.006     Document Type: Article

References (16)

1. P.A.L. Tonino, B. De Bruyne, and N.H.J. Pijls Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
2. G.W. Stone, A. Maehara, and A.J. Lansky A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
3. S.G. Ellis, S.J. Brener, and S. DeLuca Late myocardial ischemic events after saphenous vein graft intervention-importance of initially "nonsignificant" vein graft lesions Am J Cardiol 79 1997 1460 1464
4. G.L. Knatterud, C. White, and N.L. Geller Angiographic changes in saphenous vein grafts are predictors of clinical outcomes Am Heart J 145 2003 262 269
5. J. Rodes-Cabau, A. Facta, and E. Larose Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting Am J Cardiol 100 2007 640 645
6. J. Rodes-Cabau, O.F. Bertrand, and E. Larose Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions. The Moderate VEin Graft LEsion Stenting With the Taxus Stent and Intravascular Ultrasound (VELETI) pilot trial Circulation 120 2009 1978 1986
7. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
8. C. Lichtenwalter, J.A. de Lemos, and M. Roesle Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial JACC Cardiovasc Interv 2 2009 855 860
9. N. Badhey, C. Lichtenwalter, and J.A. de Lemos Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stenting of saphenous vein grafts trial Catheter Cardiovasc Interv 76 2010 263 269
10. E.S. Brilakis, C. Lichtenwalter, and A-rR Abdel-karim Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol Intv 4 2011 176 182
11. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention Circulation 97 1998 916 931
12. D.M. Boatman, B. Saeed, and I. Varghese Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events Heart Vessels 24 2009 241 246
13. E.S. Brilakis, J.A. de Lemos, and C.P. Cannon Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol 102 2008 552 558
14. S.J. Shah, D.D. Waters, and P. Barter Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery J Am Coll Cardiol 51 2008 1938 1943
15. C.C. Wee, S. Girotra, A.R. Weinstein, M.A. Mittleman, and K.J. Mukamal The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy J Am Coll Cardiol 52 2008 620 625
16. E.S. Brilakis, B. Saeed, and S. Banerjee Drug-eluting stents in saphenous vein graft interventions: a systematic review EuroIntervention 5 2010 722 730